160 related articles for article (PubMed ID: 10065626)
1. Cotton rats (Sigmodon hispidus): an animal model to study the pathogenesis of measles virus infection.
Niewiesk S
Immunol Lett; 1999 Jan; 65(1-2):47-50. PubMed ID: 10065626
[TBL] [Abstract][Full Text] [Related]
2. Current animal models: cotton rat animal model.
Niewiesk S
Curr Top Microbiol Immunol; 2009; 330():89-110. PubMed ID: 19203106
[TBL] [Abstract][Full Text] [Related]
3. Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus).
Pfeuffer J; Püschel K; Meulen Vt; Schneider-Schaulies J; Niewiesk S
J Virol; 2003 Jan; 77(1):150-8. PubMed ID: 12477820
[TBL] [Abstract][Full Text] [Related]
4. Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).
Niewiesk S
Vaccine; 2001 Mar; 19(17-19):2250-3. PubMed ID: 11257342
[TBL] [Abstract][Full Text] [Related]
5. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
6. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.
Schlereth B; Buonocore L; Tietz A; Meulen VT; Rose JK; Niewiesk S
J Gen Virol; 2003 Aug; 84(Pt 8):2145-2151. PubMed ID: 12867646
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
[TBL] [Abstract][Full Text] [Related]
8. Use of cotton rats for preclinical evaluation of measles vaccines.
Wyde PR; Stittelaar KJ; Osterhaus AD; Guzman E; Gilbert BE
Vaccine; 2000 Aug; 19(1):42-53. PubMed ID: 10924785
[TBL] [Abstract][Full Text] [Related]
9. Replication of clinical measles virus strains in hispid cotton rats.
Wyde PR; Moore-Poveda DK; Daley NJ; Oshitani H
Proc Soc Exp Biol Med; 1999 May; 221(1):53-62. PubMed ID: 10320632
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
Weidinger G; Ohlmann M; Schlereth B; Sutter G; Niewiesk S
Vaccine; 2001 Apr; 19(20-22):2764-8. PubMed ID: 11282186
[TBL] [Abstract][Full Text] [Related]
11. Measles virus 1998-2002: progress and controversy.
Rall GF
Annu Rev Microbiol; 2003; 57():343-67. PubMed ID: 14527283
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.
Schlereth B; Germann PG; ter Meulen V; Niewiesk S
J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075
[TBL] [Abstract][Full Text] [Related]
13. Cotton rat (Sigmodon hispidus) signaling lymphocyte activation molecule (CD150) is an entry receptor for measles virus.
Carsillo T; Huey D; Levinsky A; Obojes K; Schneider-Schaulies J; Niewiesk S
PLoS One; 2014; 9(10):e110120. PubMed ID: 25295727
[TBL] [Abstract][Full Text] [Related]
14. Analysis of antibody response by temperature-sensitive measles vaccine strain in the cotton rat model.
Haga T; Murayama N; Shimizu Y; Saito A; Sakamoto T; Morita T; Komase K; Nakayama T; Uchida K; Katayama T; Shinohara A; Koshimoto C; Sato H; Miyata H; Katahira K; Goto Y
Comp Immunol Microbiol Infect Dis; 2009 Sep; 32(5):395-406. PubMed ID: 18249443
[TBL] [Abstract][Full Text] [Related]
15. Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins.
Niewiesk S; Eisenhuth I; Fooks A; Clegg JC; Schnorr JJ; Schneider-Schaulies S; ter Meulen V
J Virol; 1997 Oct; 71(10):7214-9. PubMed ID: 9311794
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.
Boukhvalova M; McKay J; Mbaye A; Sanford-Crane H; Blanco JC; Huber A; Herold BC
J Virol; 2015 Oct; 89(19):9825-40. PubMed ID: 26178984
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of recombinant measles vaccine expressing fusion protein of respiratory syncytial virus in cynomolgus monkeys.
Sawada A; Yunomae K; Nakayama T
Microbiol Immunol; 2018 Feb; 62(2):132-136. PubMed ID: 29194753
[TBL] [Abstract][Full Text] [Related]
18. An immune competent mouse model for the characterization of recombinant measles vaccines.
Marty RR; Knuchel MC; Morin TN; Naim HY
Hum Vaccin Immunother; 2015; 11(1):83-90. PubMed ID: 25483519
[TBL] [Abstract][Full Text] [Related]
19. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses.
El Mubarak HS; Yüksel S; van Amerongen G; Mulder PGH; Mukhtar MM; Osterhaus ADME; de Swart RL
J Gen Virol; 2007 Jul; 88(Pt 7):2028-2034. PubMed ID: 17554037
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
